Banner

Technology in trials: Early results promising for presbyopia reversal

Article

Orlando-Early results from a clinical trial for the reversal and treatment of presbyopia, using SurgiLight Inc.'s OptiVision technology, appear "promising," according to researchers at New York-Presbyterian Hospital Weill Cornell Medical Center.

Related Videos
Related Content

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023

Tackling negotiations for contracts

September 25th 2023

EyePod: Week in Review - September 17, 2023

September 23rd 2023

Orbis International partnering with the Alcon Foundation, OMEGA to improve eye care in Zambia

September 25th 2023

EyePod: Week in Review - September 10, 2023

September 16th 2023

Editorial: Reflection uncovers importance of work-life balance

September 25th 2023

World Retina Day: Iveric Bio focusing on GA awareness with More to See campaign

September 24th 2023
© 2023 MJH Life Sciences

All rights reserved.